Plazinemdor
Plazinemdor is a N-methyl-D-aspartate (NMDA) receptor positive allosteric modulator. Plazinemdor can be uses in the research of psychiatric, neurological, and neurodevelopmental disorders, as well as diseases of the nervous system[1]..
Product Specifications
CAS Number
2378285-59-5
Product Name Alternative
CAD-9303
UNSPSC
12352005
Target
IGluR
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/plazinemdor.html
Purity
96.61
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C1C2=C(N=CN1CC(N3CC(C)(C3)F)=O)N(C4CC4)C=C2C5=CC(Cl)=C(F)C=C5
Molecular Formula
C21H19ClF2N4O2
Molecular Weight
432.85
References & Citations
[1]Anderson, David R, et, al. Preparation of heteroaromatic NMDA receptor modulator and uses thereof.US20200039987A.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Isoform
NMDA Receptor
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Cytokeratin 17 (E3), CF740 conjugate, 0.1mg/mL
CD63 (MX-49.129.5), CF488A conjugate, 0.1mg/mL
TGF-beta (1D11.16.8), CF594 conjugate, 0.1mg/mL
CD81 / TAPA-1 (1.3.3.22), CF405S conjugate, 0.1mg/mL
P21 / WAF1 (WA-1), CF568 conjugate, 0.1mg/mL
